This article was originally published in The Gray Sheet
Executive SummaryJohnson & Johnson merges the two units to form Biosense Webster. The combined firm, headquartered in Diamond Bar, California, will be "a key unit of the worldwide Cordis franchise," J&J says Aug. 12. James Dennis, former president of St. Jude Medical's Cardiac Rhythm Management Division, is named president of the business
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.